Experts question evidence of psychedelic medicines following regulatory approval

Just weeks after Australia became the first country to approve the use of MDMA and psilocybin for treating mental health conditions, the decision has drawn...

Related Keywords

Monash ,South Australia ,Australia ,Steve Kisely ,Chris Langmead ,Neuromedicines Discovery Centre At Monash ,Therapeutic Goods Administration ,Monash University ,Public Health Research Practice ,Public Health Research ,Neuromedicines Discovery Centre ,Medicine Australia ,Peter Hunt ,